These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20128866)

  • 1. What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?
    Morser J; Gabazza EC; Myles T; Leung LL
    J Thromb Haemost; 2010 May; 8(5):868-76. PubMed ID: 20128866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin-activatable fibrinolysis inhibitor but not the anti-inflammatory activity on osteopontin and C5a.
    Semeraro F; Ammollo CT; Gils A; Declerck PJ; Colucci M
    J Thromb Haemost; 2013 Dec; 11(12):2137-47. PubMed ID: 24134522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation.
    Myles T; Nishimura T; Yun TH; Nagashima M; Morser J; Patterson AJ; Pearl RG; Leung LL
    J Biol Chem; 2003 Dec; 278(51):51059-67. PubMed ID: 14525995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
    Foley JH; Kim PY; Mutch NJ; Gils A
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH; Kim P; Nesheim ME
    J Biol Chem; 2008 Apr; 283(14):8863-7. PubMed ID: 18252711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor.
    Plug T; Meijers JC
    J Thromb Haemost; 2016 Apr; 14(4):633-44. PubMed ID: 26786060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M; Incampo F; Cannavò A; Menegatti M; Siboni SM; Zaccaria F; Semeraro N; Peyvandi F
    J Thromb Haemost; 2016 Aug; 14(8):1603-14. PubMed ID: 27094709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
    Wang X; Smith PL; Hsu MY; Tamasi JA; Bird E; Schumacher WA
    J Thromb Thrombolysis; 2007 Feb; 23(1):41-9. PubMed ID: 17111204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Meijers JC
    J Thromb Haemost; 2003 Jul; 1(7):1566-74. PubMed ID: 12871292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
    Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
    Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Havik SR; Bouma BN; Meijers JC
    J Thromb Haemost; 2005 Jun; 3(6):1293-300. PubMed ID: 15946220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
    Leung LL; Myles T; Nishimura T; Song JJ; Robinson WH
    Mol Immunol; 2008 Oct; 45(16):4080-3. PubMed ID: 18706698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.
    Mao SS; Holahan MA; Bailey C; Wu G; Colussi D; Carroll SS; Cook JJ
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):407-15. PubMed ID: 16093731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
    Leung LL; Nishimura T; Myles T
    Adv Exp Med Biol; 2008; 632():61-9. PubMed ID: 19025114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
    Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
    J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-activatable fibrinolysis inhibitor.
    Marx PF
    Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.